London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: ripley94, 30 Sep 2022 11:18
Last post: ripley94, 30 Sep 2022 11:18
No idea what it could mean to me , had thought it a total loss , appears it was 2017.
05/09/2022
SPHR.L
SPHERE MEDICAL HLDG PLC ORD GBP0.01
Takeover
154,777
Started: revolutionary, 18 Sep 2019 20:12
Last post: a-2-b, 25 Sep 2019 18:04
Its actually ready in it's final test phase, needs fda approval but the institution has refused to provide further cash for the approval so it's up for sale. In a way it's probably a good state to sell it as there will be minimal work for the buyer to do plus it's automated so will fast track the whole process.
also uncannily checked for news yesterday and got the stark message. Question is what have they built with all those millions? If only we had FDA approval, someone could make a go of it somehow.
Yeah just noticed myself, though I'd check the website out after some time. Quite uncanny it was yesterday. Shame really if anyone takes it up though it's pretty much ready I guess, speaking to someone about a year back the latest model had come on leaps and bounds.
Has gone'tits up'. Admin rather than liquidation so maybe some slight hope for shareholders.
Anyone have any idea why this has just reappeared? Does anyone have any clue about who owns what joe with all those preference shares and layered companies?
Started: pa_richards, 5 Sep 2018 12:53
Last post: pa_richards, 5 Sep 2018 12:53
An interesting article on the sad demise of a US company in a related field of endevour. This may present some opportunities for SPHR in the US / highlight some of the challenges they may face now in getting traction.
https://www.bbc.co.uk/news/business-45418615
Shame, noticed this the other day personally. The site has changed a little too.
Shareholder Dealing The Company had hoped to establish and operate a matched bargain service to enable shareholders wishing to buy and sell Sphere Medical shares to find counterparties. We have received advice that because of MiFID II (the Markets in Financial Instruments Directive) it will not be possible for the Company to operate such a service.
I wonder whats going on behind the scenes at sphere now. My shares are still sat with my broker awaiting collection from alternative broker, I wonder when it'll all start moving over.
Zaha makes all the difference.....
Funny auld game is football....:-) Nice one boys!!
This is still working......
Started: JohnLewis79, 13 Oct 2017 07:47
Last post: JohnLewis79, 13 Oct 2017 07:47
Re good time to join, it’s probably true although Renken devastated the co, brought vast sp losses and massive dilution being private could give LVO the the space to deliver what R couldn’t. LVO comes from being COO and as I understand it the next phase is delivery of the automatic Proxima and US launch so about operations and R&D and he’s not coming with boasts of having a great track record of launching products that he didn’t deliver on. Hopefully he will go quietly about his business and deliver the product everyone wants, He has my best wishes not so much for the few pennies worth of shares I am left with but I think we all want to see a UK product like Proxima be successful.
Just realised LVOs new job coincided with the ftse at a new record high..(oh dear). Glad it wasn't today being Friday the 13th! ....last time this occured was back in January, Sphere at 9p! I'm staying in bed all day....
Started: JohnLewis79, 13 Oct 2017 06:47
Last post: JohnLewis79, 13 Oct 2017 06:47
Will it be third time lucky for Sphere with yesterdays news of LVO's appointment as CEO? Not sure how internal appointments to the top job turn out, there are probably stats on these but hopefully we will soon be calling him ....Lucky Lucien. I'm not superstitious but try, try and try again comes to mind you will be successful on the third attempt or perhaps two is not enough, four too many....three is perfect. The Holy Trinity....the first prime no in mathematics or we're the third planet from the sun? Lots more I'm sure but he'll I'm beginning to feel lucky myself.
Started: JohnLewis79, 12 Oct 2017 19:20
Last post: Del44, 12 Oct 2017 20:01
Well put JL....well put my good man!!
We wish the good Dr well and congratulate LVO on his new appointment as CEO. It's a great opportunity for an incoming man to make his mark on the Co which to be fair is in far better shape than when Dr R took over the reins in early 2014. LVO might turn out to be one of Napoleon's lucky generals. I know one thing for sure, I'd rather be joining Sphere as CEO now than in '14.
Started: Wbuffet999, 12 Oct 2017 18:58
Last post: Wbuffet999, 12 Oct 2017 18:58
Great, Rencken heading back home with his tail between his legs, about time! How the chairman could thank him for his achievements, vision and strategy when he demonstrated none beggars belief but I guess the legal guys are all over these type of announcements. I hope Van Os has got what it takes and I wish him all the best for the future.
Started: Del44, 12 Oct 2017 18:26
Last post: Del44, 12 Oct 2017 18:26
Completion of fundraising Sphere Medical Holding Limited, an innovative point-of-care monitoring and diagnostic devices company, announces that, further to the announcement on 21 August 2017, the Investment and Cancellation process is complete. Gross proceeds of the Investment were �5.1 million. The Company now has in issue 141,757,872 Ordinary Shares and 179,912,380 Convertible Preferred Shares. Funds managed by Woodford Investment Management Limited own 57.3% of the Company�s issued share capital and The Wales Life Sciences Investment Fund LP owns 18.8% of the Company�s issued share capital.
Started: Del44, 12 Oct 2017 18:20
Last post: Del44, 12 Oct 2017 18:20
Change of Chief Executive Officer Sphere Medical Holding Limited, an innovative point-of-care monitoring and diagnostic devices company, announces that, Luci�n van Os, currently Chief Operating Officer, is to take over as Chief Executive Officer from Wolfgang Rencken, who is stepping down from the Board this month. Luci�n joined Sphere in June 2015 as COO. He has more than 12 years� experience in the medical device industry. An engineer by background, Luci�n has significant experience in bringing new technologies and products to the market. Luci�n has previously been CEO of some small and mid-sized medtech companies and has held senior and general management positions at Medtronic and Gambro. After close to 4 years at Sphere Medical and having successfully secured the future of the Company as a privately held entity with a new strategy, Wolfgang is stepping down as CEO to spend more time back in Germany with his family. Wolfgang will remain with Sphere until at least the end of 2017 and has committed to help in any way possible to ensure a well-structured and smooth transition. David Martyr, Chairman, said, �We would like to take this opportunity to thank Wolfgang for his tremendous contributions to our Company, his strategic vision and hard work to transform and guide the Company during his time in office and wish him all the best of success and happiness in his future pursuits. We are confident that Luci�n will be an excellent leader of the Company as it enters this important new phase of development.�
Started: JohnLewis79, 12 Oct 2017 16:07
Last post: Del44, 12 Oct 2017 18:18
Wolfgang even alluded to it at one of the presentations last year...I know it looks bleak...but who knows...the application could be used in other devices that we are not aware of yet. One thing is for sure...self testing technology is here and it is thanks to devices becoming idiot proof and produced smaller that this is happening. If we manage to get a sensor that can house all the analytes of a real blood gas machine on the Proxima...then who knows where it could end up in... The new data analysis position is to use all the incoming data from the current Proxima devices currently out in the market place and already attached to patients, to utilize the sensor to the maximum....Quite a lot of data is likely coming in now from the training hospitals that have taken delivery so far...Much bigger bank of data been built up now for the product....
I take your points on notice, changes down the line and r & d. I've never been convinced we will see any benefit from the sensor being applied elsewhere, not that it's use is limited to our field but that Sphere has never shown any interest in a) licensing Proxima or b) hinted it's usefulness in other industries. Let's face it we are not exactly excelling in our preferred field, are we? If after all these years or since P3 anyway nobody but nobody as far as we know has said "blimey I want to buy that sensor its just what we need for xyz"..... Even assuming it has applicability in other areas I doubt we will see any benefits as that's way down the road from here. I mean the whole sensor would have to be reconfigured and we just dumped the guy who specialised in this field. It's a nice idea but an impractical one methinks. If we started making some serious money that might be a different matter or at least see if others were willing to co develop the sensor. Woodford will I hope keep it simple until lactate and auto are completed we should stay determined in getting P4+(5) into hospitals and earning it's keep. 510k in a couple of years and if others are interested in the sensor technology no doubt that will be reflected in an increased value for Sphere. Interested parties will be watching our progress with much interest heading towards 2020.
Started: JohnLewis79, 12 Oct 2017 06:45
Last post: Del44, 12 Oct 2017 14:05
The contracts allow for a notice period of time to be served...so we could easily have changes in the months a head... Along side the R&D...is an improved distributors deal in place....for whatever comes out of Proxima. The direct sales thing was a non starter....but we had no choice...I still think and hope that the sensor will have applications going forward for other devices as it is improved...
I think most of us are in agreement the Co needs new blood! From near 100p to less than 1/2p needs explaining although Rencken can only be held responsible for the last downward leg from c.30p. If this has been stage managed by you know who surely the first thing you would do is have a CEO ready to take over? Hell W has had enough time to sort this out. ...if he's bothered of course! With a lot less at stake here than in some of his others, NW BIO for example, perhaps he won't be giving Sphere his full attention. It's a chunk of change but not in the hundreds of millions! As Napoleon said "I would rather have a General who was lucky than good." The 'good' doctor may have been well qualified but he sure wasn't lucky and unless business has taken off since the H/Y he should walk the plank. Now that we have reverted back to a research and development Co even if for the short term, do we need a highly paid CEO costing us a small fortune? W needs to get us into the beauty parade. We have done Miss UK now it's Miss World. We know what happens to runners up....we never hear of them again.
Started: JohnLewis79, 12 Oct 2017 09:01
Last post: JohnLewis79, 12 Oct 2017 09:01
I can't be the only one who thinks the Brexit negotiations are no less than a 'dogs dinner', whether us or the Euro team it's in disarray. The supply teacher, an ex gofer from the B of E and now chief waffler for the Brexiters steers a perilous course of indecisive action. No one believes her bluff of no deal is better than a bad deal and she'll walk she's far too risk averse for that! Half the cabinet are opposed to her and her top aides Green, Hammond, Johnson & Davis are in disagreement, a bunch of mishmashers! Love him or loathe him Bojo should be at the table to stiffen Maybots resolve for was not 'self rule' enshrined in the Atlantic Charter and Statute of Westminster? Two referendums and one in Scotland overwhelmingly backed self rule here and abroad. Catalonia and Kurdistan following on. A bit more table banging is required at the talks and less chatter in Westminster.
Started: JohnLewis79, 11 Oct 2017 18:26
Last post: JohnLewis79, 11 Oct 2017 18:26
Supposedly Trouton was a co-founder but he was never on the board so I guess a back room boy/techie. Perhaps had he been elevated to the board he would have survived along with the rest of the hordes of BoD members. Who knows? Best Sphere is shot of him making way for new blood. Next get rid of the CEO and half the BoD and the co might stand a chance. I still hold a few shares and it would be great if one day they realised their potentisl,
Great slip! Nads so much more appropriate than neds! Trout on was VP business development. No business developed in 10’years - I expect he was pushed and rightly so.
Dr Troughton was a co founder of Sphere along with Dr Hendry so whether he jumped ship or took the can as VP business development (mainly chemical sensors) for the CEO we can only guess. He may have course profoundly disagreed with leaving the quoted markets and saw the writing on the wall. Incidentally the three NAD's are costing us in excess of £100k a year or were in 2016....
Started: JohnLewis79, 11 Oct 2017 17:22
Last post: JohnLewis79, 11 Oct 2017 17:22
Only that the website has several removed names and pictures, Trouton is no longer there but they haven’t removed any of the BoD or useless CEO.
How sure are you WB that those responsible for this debacle still retain their positions? A necessary 30% reduction in the wage bill won't be achieved by making redundant low to mid level employees. If you are correct this adds to my belief that our move to the private sector was orchestrated by those in the know, for if not surely the old bod would be long gone by now if for no other reason than rewarding failure. Of course were not party to bod discussions or Woodford's intentions but it sure doesn't look or smell right to me! Mind you if they announce 25 hospitals have signed up/placed orders for P I might change my mind......
Started: Wbuffet999, 11 Oct 2017 14:25
Last post: Wbuffet999, 11 Oct 2017 14:25
I meant doers but diets is probably what the skeleton staff are on now. The bid probably outnumber them!
Started: Wbuffet999, 11 Oct 2017 14:20
Last post: Wbuffet999, 11 Oct 2017 14:20
.. who oversaw the destruction are ALL still there! Surely, the co needs diets not blind, incompetents?
Started: Wbuffet999, 11 Oct 2017 14:18
Last post: Wbuffet999, 11 Oct 2017 14:18
Looks like emoyees have bitten the dust, but the CEO and board, who
Started: JohnLewis79, 11 Oct 2017 09:12
Last post: JohnLewis79, 11 Oct 2017 09:12
Wonder whether our mrkt cap is worth more than the the bods annual salaries? Leaving the SM our value was just over £500K and outside of going to the knackers yard must rate as one of the biggest destructions of capital ever (funds poured in c £75m+) for zero gain in value. Mind you our balance sheet showed shareholder funds just short of £7m or c.5 pps made up mostly of non current assets (goodwill, patents etc..). That's a large discrepancy but as we know the Sphere market never focussed on the fundamentals preferring to see the lack of progress as a fatal flaw despite the obvious improvements (CE, production, distribution & sales). I never bought into that doomsday scenario believing that value will out eventually. Well, eventually is now upon us!
Started: JohnLewis79, 11 Oct 2017 08:27
Last post: JohnLewis79, 11 Oct 2017 08:27
Thanx for that Del but I'm not sure I'm any the wiser.
Started: JohnLewis79, 10 Oct 2017 17:05
Last post: Del44, 10 Oct 2017 22:47
Salary �40,000 Sphere Medical is a dynamic company based in Cambridge UK, specialising in the development of innovative medical monitoring and diagnostic equipment. The Company�s strategy is focused on developing its flagship product, the Proxima platform for on-patient, near real-time measurement of key blood analytes (gases, electrolytes, metabolites�). Proxima is designed to benefit a wide spectrum of patients, enabling faster decision making and improved clinical outcomes, whilst reducing cost. The Company has established partnerships with renowned research hospitals enabling the on-patient use of the current generation of Proxima (CE-marked device) in the OR and the ICU, and is as a result generating a wealth of invaluable real-world data. In-house testing adds to this volume of data, including that from the next generation Proxima with a clear path towards automated operation and a greatly expanded analyte panel. We are looking for a Senior Data Analysis and Algorithms Engineer, to join the Sensor and Algorithm Development Group. The role is varied, and its scope may be adapted to play to the strengths of the successful applicant, but shall encompass two core areas. Firstly the maintenance and development of the data infrastructure, processing tools and databases to aid R&D. Secondly the development of new algorithms to enhance the performance and capabilities of the current and future versions of Proxima. Working at Sphere Medical represents the opportunity to experience first-hand the complete cycle of medical device development from initial concept generation through to regulatory approval and roll-out. As such the Company provides an environment which tests its employees whilst expanding their skillsets.
Anyone know what a Senior Data & Analysis Engineer does? Some sort of computer software geek I assume.
Started: JohnLewis79, 10 Oct 2017 12:56
Last post: JohnLewis79, 10 Oct 2017 12:56
When lactate is added that will be 14 analyte panels P can perform. Glucose alone improved the space fourfold. With lactate added this will expand the addressable Healthcare parameters once more. For instance patient monitoring in other parts of the hospital such as care for the elderly, chronic diseases and sepsis. These combined will boost P's use dramatically as these in total are much larger than Critical Care arena. Pretty sure this is a matter of some urgency for Sphere, increasing the volume of patient connections will boost Proximas leverage in Healthcare throughout hospital departments. For all we know this might already be up and running.